SGLT2 inhibitorloop diureticsHFpEFNICENHSheart failure
…ximating NICE guidelines. Following specialist recommendations, SGLT2 inhibitor prescribing increased from 4.3% to 61.6% (p<0.001), exceeding t…
10,506articles mentioning drugs
58,393drug mentions
9,496distinct drugs extracted
0%of mentions human-reviewed
All extracted drugs
Showing 2,521–2,580 of 9,496, ordered by supporting articles. Choose a drug to see its evidence.
DORIS1EFZ1EMPA1Ethionamide1FL1151FVPA1Ficerafusp alfa1GPR15L1Gepotidacin1HCW11-0061HomaIR1IPTp-SP1Ibudilast1KAN-0011KAN-0041Mec-V1Millipede881Mn1NIMBUS1NKX0191Neuroguard1Odevixibat1P-801PD-L1xVδ2 bsTCE1PHECG1PRDX41PRDX61SAP-31SR90091TD1391TN-4011TOX1Tektrotyd1XCSgel1Z-0071ZL006-051dialysate1faster aspart1β-glucan1ABATA1ATOR-40661AZD58631Aminaphtone1Aroma Sticks1BI-19101CONSORT-AI1CPNL1ChatGPT-51Compound A1ES0091Ficolin-31Frexalimab1GLE/PIB1GZMK1Gö69761HCW11-018b1HCW92181ICT011Kisqali1LAI-ART1
Articles mentioning drugs
10,506 articles · page 499 of 876tafamidisdisease modifying drugsTransthyretin cardiomyopathyUniversity Hospitals DorsetATTR-CMNational Amyloidosis Centreamyloidosistransthyretin amyloidosis
…ral was 116 (9-263) days. Three patients were on treatment with tafamidis, 6 were awaiting appointment and 1 was diagnosed with AL amyloi…
FibriCheckCatheter ablationLeeds Teaching Hospitals NHS TrustAtrial fibrillationstrokeHolter monitoring
… of CO2 emissions.Conclusion Home-based rhythm monitoring using FibriCheck improved post-ablation care by enabling rapid correlation of sy…
Saponin glycosidespulmonary arterial hypertensionpulmonary arterial hypertension (PAH)right heart failureupper respiratory tract disordersPAHMinistry of Higher Education of the Arab Republic of Egypt
…n used for wound healing and upper respiratory tract disorders. Saponin glycosides, as major constituents, are responsible for anti-inflammatory a…
hydroxychloroquinephenylbutyratepulmonary arterial hypertensionpulmonary hypertensionPulmonary hypertension (PH)pulmonary capillary haemangiomatosispulmonary veno-occlusive diseasepulmonary arterial hypertension (PAH)congenital heart diseaseIPAH
…aptive randomised placebo-controlled phase II trial to evaluate hydroxychloroquine and phenylbutyrate in pulmonary arterial hypertension caused by…
99mTc-DPDFDGnuclear cardiology taster weekRoyal Free
…modalities with the highest exposure were myocardial perfusion, 99mTc-DPD, FDG, and hybrid PET/CT imaging. Trainees rated the extent to w…
clopidogrelprasugrelNSTEACSPCI centresecond antiplatelet therapyEuropean Society of Cardiology
… established criteria for prasugrel use (CRUSADE score ≤40) and clopidogrel for higher scores or medically managed patients. A proforma wit…
92.6%
ranolazinedobutaminerefractory anginaR-ANOCA
…nginal drugs 20%) most commonly calcium channel blockers (56%), ranolazine (46%) and oral nitrates (45%).CMD was diagnosed in 58/127 patie…
GSK3β inhibitorsMarfan syndromeThoracic aortic aneurysmstherapeutic intervention
…ity to control the chondrogenic phenotype switch in vitro using GSK3β inhibitors.Studies are ongoing to define the links between aberrant extrac…
P2Y12 inhibitorsP2Y12AMIOffice for National StatisticsPulmonary oedema
…tients received more conservative AMI care, with lower rates of P2Y12 inhibitors (76% vs. 90%), lower rates of invasive angiography (28% vs. 77%…
IV diureticsNHS Englandheart failureNIHR Regional Research Delivery Network Study Support ServiceHF
…s enough uncertainty regarding safety of outpatient delivery of IV diuretics for HF to justify an RCT according to 73% of respondents in thi…
PFAcongenital heart defectsventricular hypertrophyavian model
…excised and fixed in PFA or snap-frozen for protein extraction. PFA fixed samples were processed for iodine-enhanced μCT imaging or…